Regulatory Effects of Fenofibrate and Atorvastatin on Lipoprotein A-I and Lipoprotein A-I:A-II Kinetics in the Metabolic Syndrome

OBJECTIVE: Subjects with the metabolic syndrome have reduced HDL cholesterol concentration and altered metabolism of high-density lipoprotein (Lp)A-I and LpA-I:A-II particles. In the metabolic syndrome, fenofibrate and atorvastatin may have differential effects on HDL particle kinetics. RESEARCH DES...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Chan, Dick C., Watts, Gerald F., Ooi, Esther M.M., Rye, Kerry-Anne, Ji, Juying, Johnson, Anthony G., Barrett, P. Hugh R.
Format: Artigo
Jezik:Inglês
Izdano: American Diabetes Association 2009
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2768190/
https://ncbi.nlm.nih.gov/pubmed/19651918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc09-0519
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki